|
|
G7 vows to combat antibiotic resistance
At the G7 summit in Germany earlier this month, world leaders vowed to invest in research aimed at halting the rise of antibiotic-resistant illnesses, and supported the recently released World Health Organization (WHO) global action plan on antimicrobial resistance. Read More >>
|
|
Anatara presents at BIO2015
Last week, Anatara's Chief Scientific Officer, Dr Tracey Mynott, presented a company and technology overview in the "Gastrointestinal" session of the BIO Business Forum, as part of the BIO International Convention in Philadelphia.
|
|
Anatara in the news
Anatara received strong media coverage last week on the back of our two recent announcements regarding the second DetachTM field trial and our investor update.
- "Pooey pigs could be a thing of the past" - Australian Life Scientist
- "Anatara Lifesciences Commences Second Detach Trial" - Biospace
- "ANATARA LIFESCIENCES" - Biotech Daily 18/06/15
- "Fee waiver speeds pig diarrhea treatment path to US" - Animal Pharm
- "Anatara (ANR) 90c" - Criterion, Tim Boreham, The Australian (see below)
|
|
|
|
|
|
|
|